Actively Recruiting
The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia
Led by Karolinska Institutet · Updated on 2024-10-09
250
Participants Needed
8
Research Sites
237 weeks
Total Duration
On this page
Sponsors
K
Karolinska Institutet
Lead Sponsor
K
Karolinska University Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a prospective observational study designed to evaluate Immature Platelet Fraction or Immature Platelet Count and Platelet Function Analyzer-100/200 Closure Time-ADP (in vitro bleeding time) as markers of bleeding risk in thrombocytopenic preterm neonates admitted to the Neonatal Intensive Care Unit.
CONDITIONS
Official Title
The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Have a gestational age less than 32 weeks and a birth weight 500 grams or more
- Have a platelet count less than 100 x 10⁹/L
- Have a parent or guardian willing to provide written informed consent
You will not qualify if you...
- Are not expected to survive more than 24 hours as judged by the attending neonatologist
- Have a suspected familial thrombocytopenia or platelet dysfunction based on family history or clinical signs
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 8 locations
1
Boston Children's Hospital
Boston, Massachusetts, United States, 02115
Actively Recruiting
2
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215
Not Yet Recruiting
3
Intermountain Medical Center
Murray, Utah, United States, 84107
Not Yet Recruiting
4
Utah Valley Hospital
Provo, Utah, United States, 84604
Not Yet Recruiting
5
Amsterdam University Medical Centre
Amsterdam, Netherlands
Not Yet Recruiting
6
Leiden University Medical Center
Leiden, Netherlands
Not Yet Recruiting
7
Karolinska University Hospital Huddinge campus
Huddinge, Sweden
Actively Recruiting
8
Karolinska University Hospital Solna campus, Astrid Lindgren Children's Hospital
Stockholm, Sweden
Actively Recruiting
Research Team
E
Emöke Deschmann, MD, PhD
CONTACT
M
Martha Sola-Visner, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here